Aprea Therapeutics (APRE) Misses Q4 EPS by 49c
Tweet
Share
E-mailGet Alerts APRE Hot Sheet
Join SI Premium – FREE
Aprea Therapeutics (NASDAQ: APRE) reported Q4 EPS of ($0.49). Revenue for the quarter came in at $210 thousand.
For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Textron Systems wins $231 million Navy contract for landing craft
- Datavault AI to acquire CyberCatch for $94.5M in all-cash deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
